XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventory
 3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventory Inventory
At March 31, 2024 and December 31, 2023, the Company’s inventory primarily related to ORLADEYO. Additionally, inventory included RAPIVAB and peramivir, which is manufactured for the Company’s partners.
The Company’s inventories consisted of the following (in thousands):
March 31, 2024December 31, 2023
Raw materials$7,526 $6,449 
Work-in-process16,864 17,591 
Finished goods6,990 6,242 
Total inventory$31,380 $30,282 
Reserves(1,599)(1,599)
Total inventory, net$29,781 $28,683